Brainreader Partners with Phenome Health on Landmark Million-Person Brain Health Trial Brainreader Inc. announced it is in advanced negotiations to provide its Neuroreader® software as the exclusive volumetric brain analytics platform for Phenome Health’s Beyond the Human Genome Project.
Brainreader Welcomes Dr. Basant Kumar Bajpai as QA/RA Manager Dr. Basant Bajpai, PhD. has recently joined Brainreader as our QA/RA Manager. Dr. Bajpai earned a doctorate in Neuroscience (Brain Monitoring) at Kaunas University of Technology with specialty in Trau...
Brainreader and INFINITT North America Announce Strategic Partnership INFINITT North America and Brainreader Inc. announced a strategic partnership to expand adoption of Brainreader’s FDA-cleared Neuroreader® software, which analyzes MRI scans to quickly visualize and quantify brain structures, identifying abnormalities in under ten minutes.
Precision Medicine Approach to Alzheimer’s Disease Shows Cognitive and MRI Improvements in Pilot Study Burlingame, Calif. | July 6, 2022 News provided by Apollo Health Over 80% of Patients Show Cognitive Improvement Using a Precision Medicine Protocol Amid repeated failures of traditional drug trials f...
Research Shows Physical Activity Improves Brain Health by Reducing BMI and Improving Insulin Metabolism Neurology study links exercise, metabolic health, and preserved brain volume A research study published on April 13, 2022, in Neurology —the medical journal of the American Academy of Neurology —repor...
How to Accurately Differentiate bvFTD from EOAD Using MRI Volumetric Quantification Published research highlights the role of automated brain MRI analysis in reducing dementia misdiagnosis Differentiating behavioral variant frontotemporal dementia (bvFTD) from early-onset Alzheimer’s...
Quantitative Structural MRI for Neurocognitive Disorders Cyrus A. Raji, MD, PhD Department of Neurology Washington University, St. Louis Somayeh Meysami, MD Department of Neurology David Geffen School of Medicine at UCLA Los Angeles, CA Mario F. Mendez, MD,...
Improved Detection of Subtle Mesial Temporal Sclerosis: Validation of a Commercially Available Software for Automated Segmentation of Hippocampal Volume Why Accurate Detection of Mesial Temporal Sclerosis Matters Mesial temporal sclerosis (MTS) is one of the most common and surgically treatable causes of temporal lobe epilepsy (TLE) . Accurate identif...
Brainreader Announces 3-Year R&D Partnership with Aalborg University to Advance AI in Neurodegenerative Disease Research Brainreader, a global leader in brain volumetrics and AI-driven neuroimaging software, has entered into a three-year research and development partnership with Aalborg University , one of Denmark’s lea...
Progressive Focal Gray Matter Volume Loss in a Former High School Football Player Authors: Cyrus A. Raji, MD, PhD; David A. Merrill, MD, PhD; Jorge R. Barrio, PhD; Bennet Omalu, MD, MPH; Gary W. Small, MD Journal: American Journal of Geriatric Psychiatry (October 2016) DOI: 10.1016...
Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging Hippocampal atrophy is a key imaging marker in Alzheimer’s disease (AD) and can also appear in conditions such as mesial temporal sclerosis, traumatic brain injury, depression, PTSD, and schizophrenia...
Brain Structure in Bilingual vs. Monolingual Individuals with Alzheimer’s Disease A peer-reviewed study published in the Journal of Alzheimer’s Disease examined whether bilingualism is associated with differences in brain structure among individuals with probable Alzheimer’s diseas...
